Inactive Instrument

All News Cellectar Biosciences Inc Nasdaq

Equities

US15117F3029

All News

Unlock all the news: Be the first to know and act before the market!

Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Index	Jun. 30	CI
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Index	Jun. 30	CI
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Growth Index	Jun. 30	CI
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Growth Index	Jun. 30	CI
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell Microcap Value Index	Jun. 30	CI
Cellectar Biosciences, Inc.(NasdaqCM:CLRB) added to Russell 3000E Value Index	Jun. 30	CI
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom's Macroglobulinemia Market Landscape	Jun. 28	AQ
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape	Jun. 27	AQ
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides	May. 29	AQ
Cellectar Biosciences, Inc. and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis fungoides	May. 29	CI
Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024	May. 14
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update	May. 14	AQ
Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day	May. 08	AQ
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024	May. 07	AQ
Roth MKM Raises Cellectar Biosciences' Price Target to $28 From $20, Retains Buy Rating	Mar. 28	MT
Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $11, Maintains Outperform Rating	Mar. 28	MT
Transcript : Cellectar Biosciences, Inc., 2023 Earnings Call, Mar 27, 2024	Mar. 27
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update	Mar. 27	AQ
Cellectar Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Cellectar Biosciences Inc Nasdaq

Equities

US15117F3029

All News

Filters